Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Reexamination Certificate
2005-03-09
2011-10-25
Leavitt, Maria (Department: 1633)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
C424S093100, C435S325000, C435S366000, C435S368000
Reexamination Certificate
active
08043614
ABSTRACT:
The present invention is drawn to a 3-dimensional cell-produced scaffold construct comprising fibroblasts and the extracellular matrix that has been produced and arranged by these cells. The constructs promote the differentiation, dedifferentiation and/or transdifferentiation of cells and/or formation of tissue in vitro and in vivo, while at the same time promoting cell growth, proliferation, migration, and acquisition of in vivo-like morphology.
REFERENCES:
patent: 5135851 (1992-08-01), Kajander
patent: 5770417 (1998-06-01), Vacanti et al.
patent: 6303112 (2001-10-01), Worden
patent: 6387367 (2002-05-01), Davis-Sproul et al.
patent: 7175841 (2007-02-01), Badylak et al.
patent: 7560276 (2009-07-01), Harmon et al.
patent: 2002/0119180 (2002-08-01), Yelick et al.
patent: 2002/0151050 (2002-10-01), Vacanti et al.
patent: 2002/0172705 (2002-11-01), Murphy et al.
patent: 2002/0182241 (2002-12-01), Borenstein et al.
patent: 2003/0003575 (2003-01-01), Vacanti et al.
patent: 2003/0059939 (2003-03-01), Page et al.
patent: 2003/0129751 (2003-07-01), Grikscheit et al.
patent: 2003/0161817 (2003-08-01), Young et al.
patent: 2004/0005297 (2004-01-01), Connelly et al.
patent: 2004/0033598 (2004-02-01), Vacanti et al.
patent: 2004/0057942 (2004-03-01), Vacanti et al.
patent: 2004/0086497 (2004-05-01), MacLaughlin et al.
patent: 2004/0101518 (2004-05-01), Vacanti et al.
patent: 2004/0137613 (2004-07-01), Vacanti et al.
patent: 2004/0170612 (2004-09-01), Griffith et al.
patent: 2004/0175823 (2004-09-01), Vacanti et al.
patent: 2004/0219489 (2004-11-01), Yelick et al.
patent: 2005/0002982 (2005-01-01), Mooney et al.
patent: 2006/0018886 (2006-01-01), Klimanskaya et al.
patent: 2007/0037283 (2007-02-01), Patel et al.
patent: 0282746 (1988-09-01), None
patent: WO 01/49113 (2001-07-01), None
patent: 02/20729 (2002-03-01), None
Jahan et al 2009 Freshman Engineering Clinic II Spring pp. 1-5.
Huang et al., 2002; Stress and Strain biomechanical guides for imaging Plaque Stability Chapter 15, pp. 277-286.
Vacanti et al., “Identification and Initial Characterization of Spore-Like Cells in Adult Manuals,”Journal of Cellular Biochemistry80:455-460 (2001).
Levenberg, et al., “Differentiation of human embryonic stem cells on three dimensional polymer scaffolds,” Proceed of the National Academy of Sciences 100:12741-12746 (2003).
E. Olavi Kajander, et al, “Nanobacteria from blood, the smallest culturable autonomously replicating agent on Earth”,Proceedings of SPIE—The International Society for Optical Engineering, vol. 3111, pp. 420-428, May 8, 1998.
Becker, et al., “Regeneration of the Ventricular Myocardium in Amphibians,”Nature, vol. 248, Mar. 8, 1974, pp. 145-147.
Transwell® Permeable Supports,Corning Incorporated, 2006, pp. 1-3.
Therapies,Spinal Cord Injury—Facts and Figures at a Glance, 2003, pp. 1-2.
Abe, K., et al., A Comparison of Neurotrophic Effects of Epidermal Growth Factor and Basic Fibroblast Growth Factor in Primary Cultured Neurons from Various Regions of Fetal Rat Brain, Japan.J. Pharmacol., 1990, 54:45-51.
Aguayo, A., et al., Axon-Schwann Cell Relationships in Neuropathies of Mutant Mice,Annals New York Academy of Sciences, 1979, pp. 512-531.
Aktas, G. , et al., Ultrastructural Immunolocalization of Basic Fibroblast Growth Factor in Fibroblasts and Extracellular Matrix,Histochem Cell Biol(2000), 113:227-233.
Basu, A., et al., Loss of Insulin-Like Growth Factor I Receptor-Dependent Expression of p107 and Cyclin A in Cells that Lack the Extracellular Matrix Protein Secreted Protein Acidic and Rich in Cysteine,Cell Growth and Differentiation, 1999, vol. 10, pp. 721-728.
Batchelor, P., et al., CNS Regeneration: Clinical Possibility or Basic Science Fantasy?,Journal of Clinical Neuroscience, 2003, 10:523-534.
Bell, E., et al., Production of a Tissue-Like Structure by Contraction of Collagen Lattices by Human Fibroblasts of Different Proliferative Potential in Vitro,Proc. Natl., Acad. Sci., 1979, vol. 76, No. 3, pp. 1274-1278.
Bettger, W., et al., Rapid Clonal Growth and Serial Passage of Human Deploid Fibroblasts in a Lipid-Enriched Synthetic Medium Supplemented with Epidermal Growth Factor, Insulin, and Dexamethasone,Proc. Natl. Acad. Sci., 1981, vol. 78, No. 9, pp. 5588-5592.
Bottaro, D., et al., Molecular Signaling in Bioengineered Tissue Microenvironments,Ann. N.Y. Acad. Sci., 2002, 961:143-153.
Bradshaw, A., et al., SPARC-Null Mice Display Abnormalities in the Dermis Characterized by Decreased Collagen Fibril Diameter and Reduced Tensile Strength,The Journal of Investigative Dermatology, 2003, pp. 949-955.
Brenner, K., et al., Regulation of Fibronectin Matrix Assembly by Activated Ras in Transformed Cells,Oncogene(2000) 19::3156-3163.
Butt, R., et al., Collagen Production and Replication by Cardiac Fibroblasts is Enhanced in Response to Diverse Classes of Growth Factors,European Journal of Cell Biology, 1995, 68:330-335.
Carlson, E. et al., Role of Cys41in the N-Terminal Domain of Lumican in Ex Vivo Collagen Fibrillogenesis by Cultured Corneal Stromal Cells,Biochem. J., (2003) 369:461-468.
Cukierman, E., et al., Cell Interactions with Three-Dimensional Matrices,Current Opinion in Cell Biology, 2002, 14:633-639, pp. 633-639.
Dar, A., et al., Optimization of Cardiac Cell Seeding and Distribution in 3D Porous Alginate Scaffolds,Biotechnology and Bioengineering, vol. 80, No. 3, Nov. 5, 2002, pp. 305-312.
Edgerton, V., et al., Retraining the Injured Spinal Cord,Journal of Physiology, (2001), 533.1, pp. 15-22.
Enrlich, H.P., et al., Cell Locomotion Forces Versus Cell Contraction Forces for Collagen Lattice Contradiction: An In Vitro Model of Wound Contraction,Tissue and Cell, 1990, 22:407-417.
Fukumoto, H., et al., Recombinant Human Basic Fibroblast Growth Factor (rhbFGF) Induces Secretion of Nerve Growth Factor (NGF) in Cultured Rat Astroglial Cells,Neuroscience Letters, 1991, 122:221-224.
Girton, T.S., et al., Mechanisms of Stiffening and Strengthening in Media-Equivalents Fabricated Using Glycation,ASME, 2000, vol. 122, pp. 216-223.
Gospodarowicz, D., et al., Structural Characterization and Biological Functions of Fibroblast Growth Factor,The Endocrine Society, 1987, vol. 8, No. 2, pp. 95-109.
Grinnell, F., Fibroblast Biology in Three-Dimensional Collagen Matrices,TRENDS in Cell Biology, vol. 13, No. 5, May 2003, pp. 264-269.
Grinnell, F., et al., Collagen Processing, Crosslinking, and Fibril Bundle Assembly in Matrix Produced by Fibroblasts in Long-Term Cultures Supplemental with Ascorbic Acid,Experimental Cell Research, 1989, 181:483-491.
Hata. R., et al., L-Ascorbic Acid 2-Phosphate Stimulates Collagen Accumulation, Cell Proliferation, and Formation of a Three-Dimensional Tissuelike Substance by Skin Fibroblasts,Journal of Cellular Physiology, 1989, 138:8-16.
Houle, J., et al., Repair of Chronic Spinal Cord Injury,Experimental Neurology, 2003, 182:247-260.
Huang, D., et al., Mechanisms and Dynamics of Mechanical Strengthening in Ligament-Equivalent Fibroblast-Populated Collagen Matrices,Annals of Biomedical Engineering, 1993, vol. 21, pp. 289-305.
Ishikawa, O., et al., Morphological and Biochemical Analyses on Fibroblasts and Self-Produced Collagens in a Novel Three-Dimensional Culture,British Journal of Dermatology, 1997, 136:6-11.
Jin, Y., et al., Transplants of Fibroblasts Genetically Modified to Express BDNF Promote Axonal Regeneration from Supraspinal Neurons Following Chronic Spinal Cord Injury,Experimental Neurology, 2002, 177:265-275.
Kessler, D., et al., Fibroblasts in Mechanically Stressed Collogen Lattices Assume a “Synthetic” Phenotype,The Journal of Biological Chemistry, vol. 276, No. 39, 2001 pp. 36575-36585.
King, V., et al., Mats Made from Fibronectin Support Oriented Growth of Axons in the Damaged Spinal Cord of the Adult Rat,Experimental Biology, 2003, 182:383-398.
Kurata, S., et al., Transcriptional Activation of Type I Collagen Genes by Ascorbic Acid 2-Phosphate in Human Skin Fibroblasts and Its Failure in Cells from a Patient with χ2(I)-Chain-Defective Ehler-Danlos Syndrome,
Leavitt Maria
Nevrivy Patent Law Group P.L.L.C.
LandOfFree
Autogenic living scaffolds and living tissue matrices:... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Autogenic living scaffolds and living tissue matrices:..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Autogenic living scaffolds and living tissue matrices:... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4270456